If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Massimo Montano is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 30 Similar Profiles
oxaliplatin Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Biliary Tract Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Valproic Acid Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Rectal Neoplasms Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2012 2019

  • 221 Citations
  • 6 h-Index
  • 11 Article

Clinical management of localized undifferentiated sinonasal carcinoma: our experience and review of the literature

Perri, F., Della Vittoria Scarpati, G., Ionna, F., Longo, F., Montano, M., Muto, P., Ravo, V., Giuliano, M. & Caponigro, F., Mar 2019, In : Anti-Cancer Drugs. 30, 3, p. 308-312 5 p.

Research output: Contribution to journalArticle

Therapeutics
Neoplasms
Radiotherapy
Olfactory Esthesioneuroblastoma
Neuroendocrine Carcinoma
Open Access
Electrochemotherapy
Palliative Care
Neck
Head
Neoplasms

Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study)

Leone, F., Marino, D., Cereda, S., Filippi, R., Belli, C., Spadi, R., Nasti, G., Montano, M., Amatu, A., Aprile, G., Cagnazzo, C., Fasola, G., Siena, S., Ciuffreda, L., Reni, M. & Aglietta, M., Feb 15 2016, In : Cancer. 122, 4, p. 574-581 8 p.

Research output: Contribution to journalArticle

oxaliplatin
gemcitabine
Biliary Tract Neoplasms
Survival
Disease-Free Survival

Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study)

Filippi, R., Belli, C., Spadi, R., Nasti, G., Montano, M., Amatu, A., Aprile, G., Fasola, G., Siena, S. & Ciuffreda, L., Feb 15 2016, In : Cancer. 122, 4, p. 574-581 8 p.

Research output: Contribution to journalArticle

oxaliplatin
gemcitabine
Biliary Tract Neoplasms
Survival
Disease-Free Survival
49 Citations (Scopus)

Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study)

Leone, F., Marino, D., Cereda, S., Filippi, R., Belli, C., Spadi, R., Nasti, G., Montano, M., Amatu, A., Aprile, G., Cagnazzo, C., Fasola, G., Siena, S., Ciuffreda, L., Reni, M. & Aglietta, M., Feb 15 2016, In : Cancer. 122, 4, p. 574-581 8 p.

Research output: Contribution to journalArticle

oxaliplatin
gemcitabine
Biliary Tract Neoplasms
Survival
Disease-Free Survival